What the company does
ISU Chemical makes the raw materials used in synthetic detergents, primarily linear alkylbenzene (LAB) and related petrochemical compounds, and supplies them to manufacturers of cleaning and personal-care products.
Listed on KOSPI, Korea's main stock exchange, the company operates through three divisions: petrochemicals, construction, and biopharmaceuticals. The petrochemical division, which runs plants in Ulsan and Onsan, accounts for the large majority of consolidated revenue, while the construction arm operates under the residential brand 'Brownstone' and the pharmaceutical subsidiary markets biosimilar drugs.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$1.4B
- FY2024US$1.4B
- FY2025US$1.2B
Operating profit
- FY2023−US$40.6M
- FY2024−US$37.3M
- FY2025US$5M
Net income
- FY2023−US$20.3M
- FY2024−US$27.7M
- FY2025−US$29.4M
Key ratios (FY2025)
Why it matters · Context, not a recommendation
ISU Chemical's pharmaceutical subsidiary, ISU Apgis, is a separate operating company within the consolidated group, commercializing biosimilar medicines including Clotinab, Abcertin, and Fabagal.
Filings
All disclosures · English when translatedPrice charts coming soon
Interactive price history isn't here yet. Would you use it?